TROG 09.03 (MP3)

Primary Sponsor: Trans Tasman Radiation Oncology Group (TROG)

Title

An efficacy study of Chemo-Radiotherapy in Positron Emission Tomography (PET) Merkel Cell Carcinoma of the Skin

Summary

This study aims to develop a well-tolerated chemo-radiotherapy treatment for patients with Merkel Cell Carcinoma (MCC) of the skin, which achieves high rates of cancer control.

The researchers will be looking at patients' quality of life in those receiving chemotherapy via a questionnaire that will be completed periodically throughout treatment and the follow-up after. The researches will also be looking at the value of using Positron Emission Tomography (PET – a type of imaging procedure that allows us to see anatomical structure and function that cannot usually be seen on a CT scan) to assist in tailoring the Radiation Therapy (RT) treatment plan to the extent of each participants disease.

Final Accrual

Trial Status

Closed to accrual, January 2016

Trial chairperson

Associate Professor Michael Poulsen, Mater Centre, QLD
Email: Michael.Poulsen@health.qld.gov.au

Trial contact

Narelle Wallace
Phone: +61 7 3840 3320
Email: Narelle.Wallace2@health.qld.gov.au

Further information

TROG trial 09.03 on Australian Cancer Trials website

Trial resources for TROG members

TROG 09.03 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.

Tweets by @TROGfightcancer